...
首页> 外文期刊>BMJ Open Diabetes Research & Care >The combined effect of visit-to-visit variability in HbA1c and systolic blood pressure on the incidence of cardiovascular events in patients with type 2 diabetes
【24h】

The combined effect of visit-to-visit variability in HbA1c and systolic blood pressure on the incidence of cardiovascular events in patients with type 2 diabetes

机译:HbA1c访视变异性和收缩压对2型糖尿病患者心血管事件发生率的综合影响

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective To investigate the association between long-term visit-to-visit variability in glycated hemoglobin (HbA1c) and systolic blood pressure (SBP) and the incidence of cardiovascular disease (CVD) in patients with type 2 diabetes. Methods We retrospectively enrolled 632 patients with type 2 diabetes and no history of CVD who first visited our hospital between 1995 and 1996, were followed-up for ≥1?year, attended at least 4 clinic visits and had at least 1 visit per year. Patients were followed until June 2012 at the latest, and mailed questionnaires. Results During the median follow-up period (15.4?years), 81 patients developed CVD. Multivariate analysis revealed that the coefficient of variation (CV) and the variation independent of mean (VIM) for HbA1c and SBP were significant predictors of CVD incidence independent of mean HbA1c and SBP. Patients were classified into 4 groups by median HbA1cCV and SBPCV values and by median HbA1cVIM and SBPVIM values. Among these groups, the HRs were highest in the high-HbA1cCV/high-SBPCV and high-HbA1cVIM/high-SBPVIM groups and were significantly higher compared with those in the low-HbA1cCV/low-SBPCV and low-HbA1cVIM/low-SBPVIM groups, respectively. Among patients with mean SBP≥130?mm?Hg, the HRs associated with HbA1cCV and HbA1cVIM were drastically elevated compared with those with mean SBP130?mm?Hg (interaction p0.05). Conclusions Long-term visit-to-visit variability in HbA1c and SBP represented a combined and additive risk for CVD incidence in patients with type 2 diabetes. It is suggested that a synergistic effect exists between HbA1c variability and mean SBP levels for CVD incidence.
机译:目的探讨2型糖尿病患者糖化血红蛋白(HbA1c)和收缩压(SBP)的长期访视变异与心血管疾病(CVD)发生率的关系。方法我们回顾性研究了1995年至1996年首次就诊于我院,随访≥1年,至少接受4次就诊且每年至少接受1次就诊的632例无CVD史的632例2型糖尿病患者。追踪患者至迟至2012年6月,并邮寄问卷。结果在中位随访期(15.4年)中,有81例患者发生了CVD。多变量分析显示,HbA1c和SBP的变异系数(CV)和独立于均值的变异(VIM)是独立于均值HbA1c和SBP的CVD发生率的重要预测指标。根据中位HbA1cCV和SBPCV值以及中位HbA1cVIM和SBPVIM值将患者分为4组。在这些组中,高HbA1cCV /高SBPCV和高HbA1cVIM /高SBPVIM组的HR最高,并且显着高于低HbA1cCV / low-SBPCV和低HbA1cVIM / low-SBPVIM的组组。在平均SBP≥130?mm?Hg的患者中,与平均SBP <130?mm?Hg的患者相比,与HbA1cCV和HbA1cVIM相关的HRs显着升高(相互作用p <0.05)。结论HbA1c和SBP的长期访视变异性代表了2型糖尿病患者CVD发生的合并和累加风险。建议在HbA1c变异性与CVD发生率的平均SBP水平之间存在协同作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号